Fact CheckerSign in

NCT07569250Not yet recruiting

Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization

Source: ClinicalTrials.gov · Last updated 10 Jul 2026

Brief summary (registry, in English)

The goal of this interventional study is to create and test a comprehensive and low burden text message program within existing Community Health Centers (CHC) electronic records system to encourage patients to complete at home colorectal cancer (CRC) screening and to make sure they get follow-up care if their results are abnormal. First, the investigators will learn from clinic staff and patients what their needs and preferences are in terms of use of technology. This information will be used to design the text messages program. * Clinic patients will participate in focus groups * Clinic staff will participate in interviews Second, the investigators will test a series of different message versions in two batches (experiments): * Clinic patients with orders for an at-home colorectal cancer screening kit will receive the different message versions. * In the first batch, the messages that get the most engagement from patients will be selected to be used in the second experiment. * In the second batch, the investigators will test which messages lead to the most colorectal cancer screening completion. * This will be rolled-out within the clinics existing electronic record system. The study team will not receive any information that will identify individual patients. Lastly, the investigators will check again with clinic staff to learn how the program performed, and what would be needed to continue using the text message program in the long run. -Clinic staff will participate in interviews and surveys.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
7220 (estimated)
First submitted
29 Apr 2026
Start date
1 Dec 2026
Primary completion date
31 Oct 2031
Lead sponsor
University of Colorado, Denver
NCT number
NCT07569250

What you commit to

  • Study type: Interventional
  • Planned participants: 7220
  • From 1 Dec 2026 to the primary completion date, 31 Oct 2031
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Personal or family history of CRC or colorectal polyps
  • History of inflammatory bowel disease
  • Heritable conditions that put them at above average risk for colorectal cancer (e.g., familial adenomatous polyposis)
    • Eligibility Criteria for CHC Staff Cohorts Inclusion Criteria (CHC Staff)

Other

  • Adult employees of participating CHCs
  • Job responsibilities include activities related to CRC screening
  • None

Who the study is looking for

  • Adults 45-75 years old
  • Receive care in partner CHCs
  • Are of average risk for colorectal cancer
  • Received a stool-based testing order at their CHC
  • Have a mobile phone and can receive text messages (Aim 1 quantitative cohort only)
  • Fluent in English, Spanish, or another predominant language to be identified by the PI (applicable to patients focus groups cohort only)

Criteria the registry did not label

  • Eligibility Criteria for CHC Patients Cohorts

Age in the registry: 45 years to 75 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dana-Farber Cancer Institute
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
The Massachusetts League of Community Health Center, Inc.
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
Massachusetts General Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
University of Texas Southwestern Medical Center
Coordinator of this site? Confirm its status
DallasUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.